The amino terminus of Cdk2 binds p21
N K Moskowitz1, F J Borao, O Dardashti
1University of Medicine and Dentistry of New Jersey, Cancer Institute of New Jersey, New Brunswick 08901, USA.
Abstract:
The cyclin-dependent kinase (Cdk) inhibitor known as p21, which is transcriptionally regulated by p53, can induce G1 arrest when overexpressed and inhibit the kinase activity of a wide variety of cyclin-Cdk complexes. Previous studies have demonstrated that a portion of the conserved region of p21 (amino acids 46-78), which is homologous to similar regions in the related Cdk inhibitors p27 and p57, can bind to Cdk2, and that this region is essential for kinase inhibition. However, the site(s) on Cdk2 that are involved in p21 binding have not been identified. We therefore created mutant Cdk2 molecules with various N-terminal and C-terminal deletions and tested each for their ability to bind to p21 by the yeast two-hybrid and the double-tagging assays. None of the deletion mutants tested bound to p21 by either assay. We next tested whether p21 could bind to Cdk7, a component of the cyclin-activating kinase complex. By both the double-tagging and yeast two-hybrid assays, p21 failed to bind to this protein, consistent with previous reports. However, hybrid molecules consisting of the amino-terminal half of Cdk2 and the carboxy-terminal half of Cdk7 (Cdk2/Cdk7) could bind to p21 by both assays, whereas the Cdk7/Cdk2 hybrids could not. Furthermore, the yeast Cdc28 protein, which is 65% identical with Cdk2, failed to bind to p21 by both the yeast two-hybrid and double-tagging assays. Cdk2/Cdc28 hybrids but not Cdc28/Cdk2 hybrids could bind to p21. These results suggest that the amino-terminal half of Cdk2 is important for p21 binding, consistent with the recently published crystal-lographic data. Our data also suggest that the three-dimensional structure of Cdk2 is likely altered by creating deletion mutants from either the amino- or carboxy-terminal end of the protein. Finally, we have mutated the Cdc28/Cdk2 hybrid protein and isolated several mutants, which are able to bind to p21. This approach may be useful for identifying residues in Cdk2 and Cdc28 that affect their ability to bind to p21 and complement the crystallographic data.
Insights
The cyclin-dependent kinase (Cdk) inhibitor p21 binds to Cdk2, with the amino-terminal half of Cdk2 being crucial for this interaction. This study identifies key regions in Cdk2 essential for p21 binding, aiding in understanding cell cycle regulation.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Protein-Protein Interactions
Background:
- p21 is a cyclin-dependent kinase (Cdk) inhibitor that regulates cell cycle progression by inducing G1 arrest.
- Previous research indicated that amino acids 46-78 of p21 are essential for binding to Cdk2 and inhibiting its kinase activity.
- The specific binding sites on Cdk2 for p21 have not been identified.
Purpose of the Study:
- To identify the specific region(s) on Cdk2 responsible for binding to the cyclin-dependent kinase (Cdk) inhibitor p21.
- To investigate the role of different domains of Cdk2 in mediating p21 interaction.
- To complement existing crystallographic data on Cdk2-p21 interactions.
Main Methods:
- Construction and testing of various N-terminal and C-terminal deletion mutants of Cdk2 for p21 binding.
- Utilizing yeast two-hybrid and double-tagging assays to assess protein interactions.
- Creating and analyzing Cdk2/Cdk7 and Cdk2/Cdc28 hybrid proteins to map p21 binding domains.
- Mutagenesis of hybrid proteins to identify specific residues involved in p21 binding.
Main Results:
- Deletion mutants of Cdk2 did not bind to p21, suggesting the importance of intact domains.
- Hybrid molecules revealed that the amino-terminal half of Cdk2, but not Cdk7, is critical for p21 binding.
- The yeast protein Cdc28, homologous to Cdk2, also failed to bind p21, but Cdk2/Cdc28 hybrids could bind, further implicating Cdk2's N-terminus.
- Mutagenesis of hybrid proteins yielded mutants capable of binding p21, pinpointing key residues.
Conclusions:
- The amino-terminal half of Cdk2 is essential for binding to the Cdk inhibitor p21.
- Deletion of terminal regions may alter the three-dimensional structure of Cdk2, affecting p21 interaction.
- This study provides valuable insights into the molecular basis of Cdk2-p21 interaction and offers a method for identifying critical binding residues.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex


